Guru Ownership Trend
Guru Analysis for SAB Biotherapeutics, Inc. (SABS)
SAB Biotherapeutics, Inc. (SABS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $3.25 M.
Top institutional holders include Jefferies Group.
Institutional sentiment is currently Bullish. This is evidenced by a $1.24 M net inflow during the quarter.
Recent activity highlights Jefferies Group who increased their stake by 55.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for SAB Biotherapeutics, Inc. (SABS)
Major holders include Jefferies Group ($3.46 M). According to the latest reported data, 1 tracked investment managers collectively hold approximately 903,094 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.24 M, with 1 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in SABS during the most recent reporting period.
Yes, 0 managers opened new positions in SABS, and 1 increased their existing holdings. The total reported buy value was $1.24 M.